Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 213
Gene Symbol: ALB
ALB
0.070 GeneticVariation group BEFREE A locus on chromosome 1, rs7533564 (P = 1.9 × 10(-9)), was associated with skin intrinsic fluorescence measured by SCOUT DS (excitation 375 nm, emission 435-655 nm), which remained significant after adjustment for time-weighted HbA1c (P = 1.7 × 10(-8)). rs7533564 was associated with mean HbA1c in meta-analysis (P = 0.0225), mean glycated albumin (P = 0.0029), and glyoxal hydroimidazolones (P = 0.049), an AGE measured in skin biopsy collagen, in DCCT. rs7533564 was not associated with diabetes complications in DCCT/EDIC or with SF in subjects without diabetes (nondiabetic [ND]) (N = 8,721). 27207532 2016
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.070 GeneticVariation group LHGDN Our results suggested that though TNF-alpha G-238A and G-308A polymorphisms were not involved in the pathogenesis of type 2 DM, type 2 diabetic patients carrying TNFA-A or TNF-308*2 genotype might be more susceptible to diabetic complications such as atherosclerosis. 12753658 2003
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.070 GeneticVariation group LHGDN The aim of our study was therefore to explore whether polymorphisms (TNF -308 G-->A, LTA T60N C-->A and AGER -374 T-->A) in these genes alone or together (as haplotypes) increased the risk for diabetic complications. 18575614 2008
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.070 GeneticVariation group BEFREE The aim of our study was therefore to explore whether polymorphisms (TNF -308 G-->A, LTA T60N C-->A and AGER -374 T-->A) in these genes alone or together (as haplotypes) increased the risk for diabetic complications. 18575614 2008
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.070 GeneticVariation group BEFREE Our results suggested that though TNF-alpha G-238A and G-308A polymorphisms were not involved in the pathogenesis of type 2 DM, type 2 diabetic patients carrying TNFA-A or TNF-308*2 genotype might be more susceptible to diabetic complications such as atherosclerosis. 12753658 2003
Entrez Id: 5972
Gene Symbol: REN
REN
0.050 GeneticVariation group BEFREE Studies in the paediatric population have also revealed an association of diabetes complications with genetic variants in the renin-angiotensin system, polyol pathway, lipid oxidation and folate metabolism. 17727384 2007
Entrez Id: 6927
Gene Symbol: HNF1A
HNF1A
0.040 GeneticVariation group BEFREE Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q. 8875082 1996
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.040 GeneticVariation group BEFREE The present study aims to examine the association of tumor necrosis factor-α (TNF-α) g.-308 G > A and adiponectin (ADIPOQ) g. + 45 T > G gene polymorphisms in type 2 diabetes (T2D) and its microvascular complications diabetic retinopathy (DR) and diabetic nephropathy (DN). 24655058 2014
Entrez Id: 283297
Gene Symbol: OR10A4
OR10A4
0.040 GeneticVariation group BEFREE Hp 2-2 DM individuals have been shown to be at increased risk for the development of diabetes complications, particularly diabetic cardiovascular disease (CVD). 22427005 2012
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.040 GeneticVariation group BEFREE No association of the 94T/G polymorphism in the adiponectin gene with diabetic complications. 15955133 2005
Entrez Id: 283297
Gene Symbol: OR10A4
OR10A4
0.040 GeneticVariation group BEFREE The Haptoglobin (HP) 2-2 genotype increases cardiovascular diabetes complication incidence. 26684170 2016
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.040 GeneticVariation group BEFREE A single-nucleotide polymorphism (SNP) G276T in the adiponectin gene has been associated with lower plasma adiponectin levels and insulin resistance, which are related to the prevalence of type 2 diabetes or diabetic complications of macroangiopathy. 15334388 2004
Entrez Id: 283297
Gene Symbol: OR10A4
OR10A4
0.040 GeneticVariation group BEFREE The potency of this M1/M2 switching pathway is underscored by the fact that human Hp2 polymorphisms are associated with worsened clinical outcomes for diabetic complications, including DN. 30014796 2018
Entrez Id: 2739
Gene Symbol: GLO1
GLO1
0.040 GeneticVariation group BEFREE Here, we examine a possible association of a single nucleotide polymorphism of glyoxalase 1 gene (Glo1 A332C, rs4746 or rs2736654) with the prevalence of microvascular diabetic complications in patients with type 1 and type 2 diabetes. 23775136 2013
Entrez Id: 847
Gene Symbol: CAT
CAT
0.030 GeneticVariation group BEFREE Type-2 diabetics who have TT genotype in -262C>T may have elevated risk for diabetes complications; these patients had the lowest mean catalase and HDL, as well as the highest glucose, haemoglobin A1c, cholesterol and ApoB. 22712453 2012
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
0.030 GeneticVariation group BEFREE The effect of eNOS gene polymorphisms on diabetic complications and comorbid diseases was measured. 20642368 2010
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.030 GeneticVariation group BEFREE An insertion polymorphism of the angiotensin-I converting enzyme gene (ACE) is common in humans and the higher expressing allele is associated with an increased risk of diabetic complications. 20479236 2010
Entrez Id: 5891
Gene Symbol: MOK
MOK
0.030 GeneticVariation group BEFREE Genetic variability in the RAGE gene: possible implications for nutrigenetics, nutrigenomics, and understanding the susceptibility to diabetic complications. 15937999 2005
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.030 GeneticVariation group BEFREE Angiotensin converting enzyme (ACE) polymorphism has been shown to be important in hypertension progression and also in diabetes complications, especially associated with heart disease. 26529791 2016
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
0.030 GeneticVariation group BEFREE Nitric oxide synthesized by endothelial nitric oxide synthase (eNOS) plays a key role in the regulation of endothelial function, and controversial results regarding the association of eNOS gene polymorphisms with diabetic complications have been reported. 22017289 2012
Entrez Id: 847
Gene Symbol: CAT
CAT
0.030 GeneticVariation group BEFREE Further studies are necessary to elucidate the role of catalase gene polymorphisms in the pathogenesis of diabetic complications. 17264407 2006
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.030 GeneticVariation group BEFREE We aimed to investigate the angiotensin-converting enzyme (ACE) gene polymorphism, ACE activity and their associations with diabetic complications in Turkish patients with type 2 diabetes mellitus. 16178979 2005
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
0.030 GeneticVariation group BEFREE To study putative associations of the ecNOS 4 a/b polymorphism with carotid artery intima-media thickness (IMT) and diabetic complications in young type-1 diabetic patients. 12605344 2003
Entrez Id: 6934
Gene Symbol: TCF7L2
TCF7L2
0.020 GeneticVariation group BEFREE Moreover, we observed associations between TCF7L2 variants and the following diabetic complications: diabetic retinopathy, cardiovascular disease and coronary artery disease. 22843023 2013
Entrez Id: 406938
Gene Symbol: MIR146A
MIR146A
0.020 GeneticVariation group BEFREE This study aimed to investigate whether the single-nucleotide polymorphism (SNP) rs2910164 residing within microRNA-146a (miR-146a) is associated with diabetic microvascular complications diabetic nephropathy (DN), proliferative diabetic retinopathy (PDR) or diabetic macular oedema (DME) in either Caucasian patients with type 1 (T1DM) or type 2 (T2DM) diabetes mellitus. 26997512 2016